Valeos Pharma A/S — Credit Rating and Financial Key Figures
CVR number: 39696614
Østervej 2, 4960 Holeby
tel: 20651018
Income statement (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | - 318.00 | -1 277.00 | -3 377.00 | -6 488.00 | -5 838.51 |
| Employee benefit expenses | -4.00 | - 702.00 | -4 015.00 | -6 837.00 | -9 038.53 |
| Total depreciation | -20.00 | -54.00 | -2 354.40 | ||
| EBIT | - 322.00 | -1 979.00 | -7 412.00 | -13 379.00 | -17 231.43 |
| Other financial expenses | - 194.00 | - 797.00 | -1 258.00 | -3 936.56 | |
| Pre-tax profit | - 322.00 | -2 173.00 | -8 209.00 | -14 637.00 | -21 168.00 |
| Income taxes | 71.00 | 468.00 | 1 801.00 | 3 211.00 | 4 634.01 |
| Net earnings | - 251.00 | -1 705.00 | -6 408.00 | -11 426.00 | -16 533.98 |
Assets (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Buildings | 1.00 | 49 200.10 | |||
| Machinery and equipment | 17.00 | 17.00 | 161.00 | 342.00 | 259.07 |
| Advance payments and construction in progress | 412.00 | 19 240.00 | 40 307.00 | 50 379.00 | |
| Tangible assets total | 429.00 | 19 257.00 | 40 469.00 | 50 721.00 | 49 459.16 |
| Investments total | |||||
| Non-current other receivables | 265.00 | 332.00 | 333.00 | 388.00 | 431.41 |
| Long term receivables total | 265.00 | 332.00 | 333.00 | 388.00 | 431.41 |
| Semifinished products | 463.34 | ||||
| Finished products/goods | 1 021.50 | ||||
| Inventories total | 1 484.84 | ||||
| Prepayments and accrued income | 160.00 | 557.00 | 451.95 | ||
| Current other receivables | 214.00 | 2 050.00 | 1 815.00 | 2 443.00 | 1 866.20 |
| Current deferred tax assets | 71.00 | 539.00 | 1 807.00 | 3 204.00 | 7 401.54 |
| Short term receivables total | 285.00 | 2 589.00 | 3 782.00 | 6 204.00 | 9 719.69 |
| Cash and bank deposits | 102.00 | 68.00 | 5 359.00 | ||
| Cash and cash equivalents | 102.00 | 68.00 | 5 359.00 | ||
| Balance sheet total (assets) | 1 081.00 | 22 246.00 | 49 943.00 | 57 313.00 | 61 095.10 |
Equity and liabilities (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 400.00 | 400.00 | 515.00 | 515.00 | 526.69 |
| Share premium account | 140.00 | 140.00 | 140.00 | 140.00 | 140.00 |
| Retained earnings | - 251.00 | 22 285.00 | 15 877.00 | 7 439.25 | |
| Profit of the financial year | - 251.00 | -1 705.00 | -6 408.00 | -11 426.00 | -16 533.98 |
| Shareholders equity total | 289.00 | -1 416.00 | 16 532.00 | 5 106.00 | -8 428.04 |
| Provisions | 6.00 | ||||
| Capital loans | 433.00 | 21 087.00 | 22 729.00 | 26 061.00 | 26 566.64 |
| Non-current loans from credit institutions | 1 000.00 | 8 232.00 | 8 498.00 | 19 786.59 | |
| Non-current other liabilities | 17.00 | 147.00 | 147.00 | 152.00 | 156.95 |
| Non-current liabilities total | 450.00 | 22 234.00 | 31 108.00 | 34 711.00 | 46 510.19 |
| Current loans from credit institutions | 13 561.00 | 17 650.58 | |||
| Current trade creditors | 118.00 | 778.00 | 1 583.00 | 3 304.00 | 4 529.70 |
| Current owed to participating | 200.00 | 204.00 | 208.00 | 212.00 | 216.49 |
| Other non-interest bearing current liabilities | 24.00 | 446.00 | 506.00 | 419.00 | 616.19 |
| Current liabilities total | 342.00 | 1 428.00 | 2 297.00 | 17 496.00 | 23 012.95 |
| Balance sheet total (liabilities) | 1 081.00 | 22 246.00 | 49 943.00 | 57 313.00 | 61 095.10 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.